[PDF] Top 20 Tratamento do lixiviado de aterro de resíduos sólidos urbanos por processo Fenton
Has 10000 "Tratamento do lixiviado de aterro de resíduos sólidos urbanos por processo Fenton" found on our website. Below are the top 20 most common "Tratamento do lixiviado de aterro de resíduos sólidos urbanos por processo Fenton".
<p>Evaluating vandetanib in the treatment of medullary thyroid cancer: patient-reported outcomes</p>
... with vandetanib, a reversal of the hypercortisolism was shown, with no changes in tumor ...The treatment was interrupted 2 times, the fi rst for 45 days owing to side effects and the second for 10 days to ... See full document
17
Clinical utility of vandetanib in the treatment of patients with advanced medullary thyroid cancer
... Abstract: Vandetanib (ZD6474) became the first systemic agent to be approved for the treatment of metastatic or locally advanced medullary thyroid ...taking vandetanib compared with ... See full document
6
Vandetanib and Lenvatinib for the Treatment of Thyroid Cancers
... for thyroid cancer ...differentiated thyroid cancers and medullary thyroid cancers, subsets of thyroid ...differentiated thyroid cancers and point mutations were observed ... See full document
27
Vandetanib induces a marked anti-tumor effect and amelioration of ectopic Cushing’s syndrome in a medullary thyroid carcinoma patient
... the treatment of symptomatic, progressive MTC in patients with locally advanced, unresectable or metastatic ...of vandetanib; however, to date, no tumor size reduction has been reported in Ectopic ... See full document
20
Patterns of thyroid hormone levels in pediatric medullary thyroid carcinoma patients on vandetanib therapy
... (selective cancer therapy) associated with the development of MTC seem promising to treat progressive and advanced MTC ...of vandetanib for adults with MTC in which 90% of patients enrolled had prior ... See full document
6
Selective use of vandetanib in the treatment of thyroid cancer
... of vandetanib in patients with MTC in long-term treatments could be overcome by the resistance to the drug that could arise from the activation of alternate mitogenic ...the treatment could be ameliorated ... See full document
27
<p>Feasibility and Utility of Incorporating Patient-Reported Outcomes into Surveillance Strategies for Advanced Lung Cancer</p>
... “ reported outcomes ” AND “ advanced lung cancer ” with the restricted publication date “ last 5 years ” ...included, treatment, instruments were used to asses QoL and timing for data ... See full document
6
Role of vandetanib in the management of medullary thyroid cancer
... either vandetanib (231) or placebo ...blinded treatment: 111 (48%) were randomly assigned to vandetanib and 28 (28%) to ...receiving vandetanib compared with placebo (hazard ratio [HR], ... See full document
9
<p>Personalized treatment options for thyroid cancer: current perspectives</p>
... anaplastic thyroid cancer (ATC) and recognize genetic mutations of potential diag- nostic, prognostic, and therapeutic implication ...of thyroid cancer genetic ...better thyroid ... See full document
7
<p>A Patient-Reported Outcomes Analysis Of Lanreotide In The Treatment Of NETs Patients With Carcinoid Syndrome: Evidence From The ELECT Trial</p>
... baseline patient-reported ...for treatment and control was explored through cumulative distribution of response ...for patient-reported outcomes (PROs), as well as the approach ... See full document
9
<p>Patient Perspective in the Development of Electronic Patient-Reported Outcomes (ePROs) in Seizure Disorders: A Patient-Centric Approach</p>
... and patient- centeredness of medical care in a variety of ...individual patient level to improve interactions between patients and ...decisions, evaluating care quality, and identifying the impacts ... See full document
6
Advanced medullary thyroid cancer: pathophysiology and management
... either vandetanib at a dose of 300 mg daily or ...receive vandetanib (hazard ratio ...to vandetanib compared with RET M918T mutation-negative ... See full document
72
<p>Patient-Reported Outcomes (PROs) in COPD Clinical Trials: Trends and Gaps</p>
... Chronic obstructive pulmonary disease (COPD) is a global health issue, with pro- gressive morbidity and high mortality incurring huge societal costs. 1–3 It is charac- terized by persistent symptoms such as dyspnea, ... See full document
7
<p>Nonadherence to Treatment and Patient-Reported Outcomes of Psoriasis During the COVID-19 Epidemic: A Web-Based Survey</p>
... primary treatment as the exposure variable, measured by a single question “During the epidemic, were you adhere to the medication or treat- ment prescribed by the physician?” with the following three responses: ... See full document
6
Molecular profiling of thyroid cancer subtypes using large-scale text mining
... With the subtype classification, we generated ranked gene lists for each subtype as discussed in the Methods section (see Table 4 for the statistics). The top 20 genes for each subtype are given in Table 5 (the full ... See full document
7
Pattern of Thyroid Cancer at King Abdulaziz University Hospital, Jeddah: A 10 Year Retrospective Study
... Data were analyzed using the Statistical Package for Social Science (SPSS Inc., IBM, US), version 16. Mean ± standard deviation (SD) was calculated for quantitative data and proportions for categorical variables. The ... See full document
227
<p>Cancer Patient-Reported Preferences and Knowledge for Liquid Biopsies and Blood Biomarkers at a Comprehensive Cancer Center</p>
... for cancer diagnosis and management has advantages: liquid biopsy results often have high concordance with tissue-based assessments; 7–9 patients are accustomed to having blood drawn at routine clinic visits, ... See full document
23
<p>The Blood Biomarkers of Thyroid Cancer</p>
... of cancer, and calprotectin is involved in the occurrence and development of various in fl ...malignant thyroid cancer which has aggressive characteristics would has increased calprotectin ... See full document
14
<p>An Update on Health-Related Quality of Life and Patient-Reported Outcomes in Hidradenitis Suppurativa</p>
... Three hundred patients with HS showed diminished QoL and sexual health (Female Sexual Function Index: 21·6 ± 9·6, International Index of Erectile Function: 49·7 ± 20·7, Arizona Sexual Experience Scale: 16·7 ± 5·3, ... See full document
14
<p>Lubiprostone in the treatment of chronic idiopathic constipation: an update on health-related quality of life and patient-reported outcomes</p>
... on treatment outcomes specifically relevant to ...of patient care are addressed within the journal and practitioners from all disciplines are invited to submit their work as well as healthcare ... See full document
9
Related subjects